Profile change history

What changed for Daptomycin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Daptomycin identity.

102Total events
102Record additions
0Version changes
17Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 102 connected records →

Showing the latest 100 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00093067

PeptideScanner retained ClinicalTrials.gov record NCT00093067 at 2026-11-15T22:01:45.056Z. Its registry update date was 2017-02-13, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
February 13, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00295178

PeptideScanner retained ClinicalTrials.gov record NCT00295178 at 2026-11-15T22:01:45.056Z. Its registry update date was 2017-09-07, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
September 7, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00428844

PeptideScanner retained ClinicalTrials.gov record NCT00428844 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-01-31, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
January 31, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00467272

PeptideScanner retained ClinicalTrials.gov record NCT00467272 at 2026-11-15T22:01:45.056Z. Its registry update date was 2021-02-08, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
February 8, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00538694

PeptideScanner retained ClinicalTrials.gov record NCT00538694 at 2026-11-15T22:01:45.056Z. Its registry update date was 2019-11-14, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
November 14, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00540072

PeptideScanner retained ClinicalTrials.gov record NCT00540072 at 2026-11-15T22:01:45.056Z. Its registry update date was 2019-11-14, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
November 14, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00663403

PeptideScanner retained ClinicalTrials.gov record NCT00663403 at 2026-11-15T22:01:45.056Z. Its registry update date was 2015-12-30, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
December 30, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00701636

PeptideScanner retained ClinicalTrials.gov record NCT00701636 at 2026-11-15T22:01:45.056Z. Its registry update date was 2016-08-29, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
August 29, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00711802

PeptideScanner retained ClinicalTrials.gov record NCT00711802 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-09-05, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
September 5, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00772447

PeptideScanner retained ClinicalTrials.gov record NCT00772447 at 2026-11-15T22:01:45.056Z. Its registry update date was 2015-03-09, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
March 9, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00882557

PeptideScanner retained ClinicalTrials.gov record NCT00882557 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-02-06, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
February 6, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00942149

PeptideScanner retained ClinicalTrials.gov record NCT00942149 at 2026-11-15T22:01:45.056Z. Its registry update date was 2013-07-15, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
July 15, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01012089

PeptideScanner retained ClinicalTrials.gov record NCT01012089 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-06-06, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
June 6, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01080963

PeptideScanner retained ClinicalTrials.gov record NCT01080963 at 2026-11-15T22:01:45.056Z. Its registry update date was 2012-04-17, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
April 17, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01184872

PeptideScanner retained ClinicalTrials.gov record NCT01184872 at 2026-11-15T22:01:45.056Z. Its registry update date was 2012-07-13, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
July 13, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01191840

PeptideScanner retained ClinicalTrials.gov record NCT01191840 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-01-05, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
January 5, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01419184

PeptideScanner retained ClinicalTrials.gov record NCT01419184 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-09-05, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
September 5, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01549613

PeptideScanner retained ClinicalTrials.gov record NCT01549613 at 2026-11-15T22:01:45.056Z. Its registry update date was 2014-08-01, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
August 1, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01626560

PeptideScanner retained ClinicalTrials.gov record NCT01626560 at 2026-11-15T22:01:45.056Z. Its registry update date was 2015-03-20, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
March 20, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01728376

PeptideScanner retained ClinicalTrials.gov record NCT01728376 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-08-28, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
August 28, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01792804

PeptideScanner retained ClinicalTrials.gov record NCT01792804 at 2026-11-15T22:01:45.056Z. Its registry update date was 2020-05-27, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
May 27, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01922011

PeptideScanner retained ClinicalTrials.gov record NCT01922011 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-08-28, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
August 28, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02660346

PeptideScanner retained ClinicalTrials.gov record NCT02660346 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-02-01, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
February 1, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02972983

PeptideScanner retained ClinicalTrials.gov record NCT02972983 at 2026-11-15T22:01:45.056Z. Its registry update date was 2020-09-22, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
September 22, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03138733

PeptideScanner retained ClinicalTrials.gov record NCT03138733 at 2026-11-15T22:01:45.056Z. Its registry update date was 2026-10-07, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
October 7, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03426761

PeptideScanner retained ClinicalTrials.gov record NCT03426761 at 2026-11-15T22:01:45.056Z. Its registry update date was 2023-10-03, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
October 3, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04775953

PeptideScanner retained ClinicalTrials.gov record NCT04775953 at 2026-11-15T22:01:45.056Z. Its registry update date was 2024-12-10, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
December 10, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04983901

PeptideScanner retained ClinicalTrials.gov record NCT04983901 at 2026-11-15T22:01:45.056Z. Its registry update date was 2026-04-06, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
April 6, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05137119

PeptideScanner retained ClinicalTrials.gov record NCT05137119 at 2026-11-15T22:01:45.056Z. Its registry update date was 2026-05-06, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
May 6, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07148960

PeptideScanner retained ClinicalTrials.gov record NCT07148960 at 2026-11-15T22:01:45.056Z. Its registry update date was 2026-09-17, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
September 17, 2026
Evidence lane
Clinical trials
Record added

Federal Register notice 2019-03129

The Federal Register published notice 2019-03129, attributed to FDA and its parent HHS department, on 2019-02-25. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
February 25, 2019
Evidence lane
Regulatory
Record added

Federal Register notice 2019-06385

The Federal Register published notice 2019-06385, attributed to FDA and its parent HHS department, on 2019-04-02. Its official title is “Post-Marketing Pediatric-Focused Product Safety Reviews; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
April 2, 2019
Evidence lane
Regulatory
Record added

Federal Register notice 2020-23439

The Federal Register published notice 2020-23439, attributed to FDA and its parent HHS department, on 2020-10-22. Its official title is “21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
October 22, 2020
Evidence lane
Regulatory
Record added

Federal Register notice 2021-25111

The Federal Register published notice 2021-25111, attributed to FDA and its parent HHS department, on 2021-11-18. Its official title is “Discovery Therapeutics, LLC, et al.; Withdrawal of Approval of 18 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin and Eptifibatide.

PeptideScanner change date
November 15, 2026
Cited source date
November 18, 2021
Evidence lane
Regulatory
Record added

Federal Register notice 2022-01693

The Federal Register published notice 2022-01693, attributed to FDA and its parent HHS department, on 2022-01-28. Its official title is “21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
January 28, 2022
Evidence lane
Regulatory
Record added

Federal Register notice 2023-16775

The Federal Register published notice 2023-16775, attributed to FDA and its parent HHS department, on 2023-08-07. Its official title is “Determination That CUBICIN (Daptomycin) Powder for Injection, 250 Milligrams/Vial and 500 Milligrams/Vial, and CUBICIN RF (Daptomycin) Powder for Injection, 500 Milligrams/Vial, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
August 7, 2023
Evidence lane
Regulatory
Record added

Federal Register notice 2023-24120

The Federal Register published notice 2023-24120, attributed to FDA and its parent HHS department, on 2023-11-01. Its official title is “Determination That CALCIUM DISODIUM VERSENATE (Edetate Calcium Disodium) Injection, 200 Milligrams per Milliliter, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
November 1, 2023
Evidence lane
Regulatory
Record added

Federal Register notice 2025-06048

The Federal Register published notice 2025-06048, attributed to FDA and its parent HHS department, on 2025-04-09. Its official title is “21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
April 9, 2025
Evidence lane
Regulatory
Record added

Federal Register notice E6-1069

The Federal Register published notice E6-1069, attributed to FDA and its parent HHS department, on 2006-01-30. Its official title is “Anti-Infective Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
January 30, 2006
Evidence lane
Regulatory
Record added

Federal Register notice E6-9225

The Federal Register published notice E6-9225, attributed to FDA and its parent HHS department, on 2006-06-14. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; CUBICIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
June 14, 2006
Evidence lane
Regulatory
Record added

Bone penetration of daptomycin in diabetic patients with bacterial foot infections.

PubMed lists PMID 31096056 in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases as Clinical Trial, Journal Article, with publication-date metadata of 2019-05-13 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 24, 2019
Evidence lane
Literature metadata
Record added

MprF-mediated daptomycin resistance.

PubMed lists PMID 31182276 in International journal of medical microbiology : IJMM as Journal Article, Review, with publication-date metadata of 2019-06-04 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 21, 2019
Evidence lane
Literature metadata
Record added

Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review.

PubMed lists PMID 31207214 in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases as Journal Article, Systematic Review, with publication-date metadata of 2019-06-14 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 2, 2022
Evidence lane
Literature metadata
Record added

Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.

PubMed lists PMID 31284042 in International journal of antimicrobial agents as Journal Article, Meta-Analysis, with publication-date metadata of 2019-07-05 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 14, 2020
Evidence lane
Literature metadata
Record added

The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-a…

PubMed lists PMID 32321574 in Antimicrobial resistance and infection control as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2020-04-22 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 22, 2025
Evidence lane
Literature metadata
Record added

Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant Enterococcus faecium: A Focused Review of Linezolid and Daptomycin.

PubMed lists PMID 32506921 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2020-06-08 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 25, 2020
Evidence lane
Literature metadata
Record added

DAPTOMYCIN, its membrane-active mechanism vs. that of other antimicrobial peptides.

PubMed lists PMID 32526177 in Biochimica et biophysica acta. Biomembranes as Journal Article, Research Support, N.I.H., Extramural, Review, with publication-date metadata of 2020-06-09 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 6, 2021
Evidence lane
Literature metadata
Record added

Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.

PubMed lists PMID 32533859 in Pharmacotherapy as Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, with publication-date metadata of 2020-07-06 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 18, 2021
Evidence lane
Literature metadata
Record added

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.

PubMed lists PMID 32725216 in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Equivalence Trial, with publication-date metadata of 2021-05-04 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.

PubMed lists PMID 32839217 in Antimicrobial agents and chemotherapy as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2020-10-20 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 17, 2021
Evidence lane
Literature metadata
Record added

Clinical Pharmacokinetics of Daptomycin.

PubMed lists PMID 33313994 in Clinical pharmacokinetics as Journal Article, Review, with publication-date metadata of 2020-12-14 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 10, 2026
Evidence lane
Literature metadata
Record added

What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant Staphylococcus aureus bacteraemia? A review.

PubMed lists PMID 33563707 in Postgraduate medical journal as Journal Article, Review, with publication-date metadata of 2021-02-09 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 23, 2021
Evidence lane
Literature metadata
Record added

The Antibiotic Peptide Daptomycin Functions by Reorganizing the Membrane.

PubMed lists PMID 33620544 in The Journal of membrane biology as Journal Article, Review, with publication-date metadata of 2021-02-23 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 10, 2026
Evidence lane
Literature metadata
Record added

Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: A Systematic Review and Meta-Analysis.

PubMed lists PMID 33728980 in Microbial drug resistance (Larchmont, N.Y.) as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2021-03-15 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 21, 2021
Evidence lane
Literature metadata
Record added

Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis.

PubMed lists PMID 34439067 in Antibiotics (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2021-08-21 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 30, 2021
Evidence lane
Literature metadata
Record added

The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis.

PubMed lists PMID 34568377 in Frontiers in medicine as Systematic Review, Journal Article, with publication-date metadata of 2021-09-10 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 29, 2021
Evidence lane
Literature metadata
Record added

Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network…

PubMed lists PMID 35656305 in Frontiers in pharmacology as Systematic Review, Journal Article, with publication-date metadata of 2022-05-17 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 16, 2022
Evidence lane
Literature metadata
Record added

Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM.

PubMed lists PMID 35786589 in Biological & pharmaceutical bulletin as Journal Article, Meta-Analysis, with publication-date metadata of 2022 (year precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 6, 2022
Evidence lane
Literature metadata
Record added

Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review.

PubMed lists PMID 36227704 in The Journal of antimicrobial chemotherapy as Systematic Review, Journal Article, with publication-date metadata of 2022-12-23 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 8, 2023
Evidence lane
Literature metadata
Record added

Bacterial cell membranes and their role in daptomycin resistance: A review.

PubMed lists PMID 36452455 in Frontiers in molecular biosciences as Journal Article, Review, with publication-date metadata of 2022-11-14 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 17, 2023
Evidence lane
Literature metadata
Record added

Daptomycin for the treatment of acute bacterial meningitis: A narrative review.

PubMed lists PMID 36870402 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2023-03-02 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 5, 2023
Evidence lane
Literature metadata
Record added

Daptomycin as an option for lock therapy: a systematic literature review.

PubMed lists PMID 37622290 in Future microbiology as Journal Article, Systematic Review, with publication-date metadata of 2023-08-25 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 22, 2024
Evidence lane
Literature metadata
Record added

Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant Staphylococcus aureus bloodstream infections: a case series and literature review.

PubMed lists PMID 38606836 in Journal of chemotherapy (Florence, Italy) as Journal Article, Review, Case Reports, with publication-date metadata of 2024-04-12 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 30, 2024
Evidence lane
Literature metadata
Record added

Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series.

PubMed lists PMID 39028390 in Infection as Systematic Review, Journal Article, Case Reports, with publication-date metadata of 2024-07-19 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 11, 2025
Evidence lane
Literature metadata
Record added

Daptomycin treatment for persistent bacteremia in a pediatric solid organ transplant recipient: Case report and literature review.

PubMed lists PMID 39216593 in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy as Journal Article, Case Reports, Review, with publication-date metadata of 2024-08-30 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 19, 2025
Evidence lane
Literature metadata
Record added

Evaluation of Daptomycin Use in Outpatients With Methicillin-Sensitive Staphylococcus aureus Bloodstream Infections.

PubMed lists PMID 39896981 in Open forum infectious diseases as Clinical Trial, Journal Article, with publication-date metadata of 2025-01-17 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 4, 2025
Evidence lane
Literature metadata
Record added

Use of Daptomycin to Manage Severe MRSA Infections in Humans.

PubMed lists PMID 40558207 in Antibiotics (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2025-06-18 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 27, 2025
Evidence lane
Literature metadata
Record added

Molecular mechanisms of resistance and tolerance of Staphylococcus aureus to daptomycin.

PubMed lists PMID 41297715 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2025-11-24 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata